Tissue Regenix Group plc (AIM: TRX)
London
· Delayed Price · Currency is GBP · Price in GBX59.50
-2.50 (-4.03%)
Sep 11, 2024, 5:33 PM GMT+1
Tissue Regenix Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -1.1 | -1.71 | -2.7 | -4.79 | -12.47 | -6.97 | Upgrade
|
| Depreciation & Amortization | 1.02 | 0.98 | 1.14 | 1.09 | 1.05 | 1.05 | Upgrade
|
| Other Amortization | 0.16 | 0.16 | 0.09 | 0.08 | 0.08 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 7.87 | 1.31 | Upgrade
|
| Stock-Based Compensation | 0.34 | 0.34 | 0.25 | 0.11 | -0.04 | -0.15 | Upgrade
|
| Other Operating Activities | 1.18 | 1.51 | 0.55 | 1.01 | 1.6 | 0.43 | Upgrade
|
| Change in Accounts Receivable | 0.76 | 1.07 | -0.7 | -0.51 | -0.26 | 1.08 | Upgrade
|
| Change in Inventory | -1.35 | 0.52 | -1.16 | -0.12 | -4.12 | -1.86 | Upgrade
|
| Change in Accounts Payable | -0.64 | -1.84 | 1.25 | 0.16 | 0.22 | -1.57 | Upgrade
|
| Operating Cash Flow | 0.36 | 1.04 | -1.29 | -2.98 | -6.06 | -6.68 | Upgrade
|
| Capital Expenditures | -0.46 | -0.41 | -0.38 | -1.55 | -1.57 | -0.44 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.54 | -0.45 | -0.71 | -0.5 | -0.29 | -0.21 | Upgrade
|
| Other Investing Activities | 0.02 | 0.03 | 0.01 | 0 | 0 | 0.02 | Upgrade
|
| Investing Cash Flow | -0.98 | -0.84 | -1.08 | -2.04 | -1.86 | -0.63 | Upgrade
|
| Long-Term Debt Issued | - | - | 1.71 | 0.6 | 0.72 | 6.48 | Upgrade
|
| Long-Term Debt Repaid | - | -0.38 | -0.07 | -0.1 | - | -4.19 | Upgrade
|
| Net Debt Issued (Repaid) | 0.81 | -0.38 | 1.64 | 0.5 | 0.72 | 2.29 | Upgrade
|
| Issuance of Common Stock | 0.18 | 0.07 | 0.01 | - | 18.67 | 0 | Upgrade
|
| Other Financing Activities | -0.95 | -1.21 | -0.74 | -0.69 | -1.7 | -0.38 | Upgrade
|
| Financing Cash Flow | 0.03 | -1.51 | 0.91 | -0.19 | 17.68 | 1.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | 0.01 | -0.29 | -0.05 | 0.08 | -0.02 | Upgrade
|
| Net Cash Flow | -0.6 | -1.3 | -1.76 | -5.26 | 9.85 | -5.44 | Upgrade
|
| Free Cash Flow | -0.1 | 0.63 | -1.68 | -4.53 | -7.63 | -7.12 | Upgrade
|
| Free Cash Flow Margin | -0.31% | 2.13% | -6.84% | -22.92% | -46.31% | -54.63% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.01 | -0.02 | -0.06 | -0.17 | -0.61 | Upgrade
|
| Cash Interest Paid | 0.85 | 0.85 | 0.74 | 0.69 | 0.55 | 0.38 | Upgrade
|
| Cash Income Tax Paid | - | -0.27 | -0.19 | -0.62 | -0.88 | -0.65 | Upgrade
|
| Levered Free Cash Flow | -1.2 | -0.74 | -2.36 | -3.65 | -7.47 | -6.62 | Upgrade
|
| Unlevered Free Cash Flow | -0.9 | -0.25 | -1.93 | -3.24 | -7.19 | -6.32 | Upgrade
|
| Change in Net Working Capital | 0.81 | -0.23 | 0.47 | -0.12 | 3.66 | 2.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.